Skip to main content

This job has expired

Associate Director for the Chromatographic and Bioanalysis Department

Employer
Charles River Laboratories - Scotland
Location
Tranent, East Lothian (GB)
Salary
£55,000 - £60,000 + 8% Pension contribution, Private HealthCare and many other benefits.
Start date
4 Aug 2022
Closing date
3 Sep 2022

View more

Discipline
Clinical Research, Drug Safety, R & D , Biology, Laboratory, Scientific
Hours
Full Time
Contract Type
Permanent
Experience Level
Management

Job Details

Charles River Laboratories Edinburgh Ltd. Are looking for an Associate Director with extensive experience to join our Chromatographic Bioanalysis team in Edinburgh, Scotland.

With a background in Bioanalysis you will be an expert in your field with experience of leading groups that work to regulated quality standards.

You will join a dynamic, actively growing team who work in partnership with Clients to support the development of new drugs across a diverse number of indications and molecular scaffolds.

Reporting directly to the Director of Chromatographic Bioanalysis and Residues, you will require industry experience combined with a strategic understanding of Bioanalytical best practice.

Role and Responsibilities

  • You will have robust oversight of preclinical and clinical assays to meet regulatory requirements in compliance with best practice and relevant regulatory standards
  • You will ensure ongoing compliance, data integrity and technical oversight of all work carried out
  • You will support the recruitment and retention of key talent to maintain a high-performing team inclusive of training and development of bioanalytical personnel
  • You will contribute to the leadership, management, and strategic growth of the team Charles River Laboratories, Edinburgh
  • You will represent chromatographic bioanalysis as a subject matter expert within Charles River and create positive relationships with internal colleagues and clients
  • You will support business development activities inclusive of limited business travel
  • You will host regulatory audits relevant to the bioanalytical discipline
  • You will contribute to metrics driven quality systems

Requirements

  • An established track record of leading teams working in drug development gained within a pharmaceutical company or a CRO
  • Deep understanding of current regulatory and quality frameworks for bioanalytical studies
  • Significant expertise in the application of chromatographic bioanalysis techniques in support of preclinical and clinical drug development.
  • Strong people skills, ability to operate with multiple partners and interfaces and develop operating models
  • Able to successfully collaborate with cross-functional teams to secure best outcomes for our Clients

If you believe you can Be The Difference and want to be part of a global team at the forefront of medical advances please apply.

In this, our 75th anniversary, we are proud to have been making a positive difference to the quality of peoples lives globally. Each and everyone of us is a valuable contributor to delivering our mission, respected for our differences and the difference we

make.

Our moment is now.    Will this be the day you find yours?    Dare to discover and apply today.

About Charles River

Charles River is an early-stage contract research organisation (CRO). We have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, to support clients from target identification through preclinical development. Charles River also provides a suite of products and services to support our clients’ clinical laboratory testing needs and manufacturing activities. Utilizing this broad portfolio of products and services enables our clients to create a more flexible drug development model, which reduces their costs, enhances their productivity and effectiveness to increase speed to market.

February 16, 2022 07:00 AM Eastern Standard Time

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the fourth-quarter and full-year 2021 and reaffirmed guidance for 2022. For the quarter, revenue was $905.1 million, an increase of 14.4% from $791.0 million in the fourth quarter of 2020.

CARE     LEAD     OWN     COLLABORATE

Company

Find out more about working for our company

crl career hub button

Brief Company Description;

Charles River is an early-stage contract research organization (CRO). We have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, to support clients from target identification through preclinical development. Charles River also provides a suite of products and services to support our clients’ clinical laboratory testing needs and manufacturing activities. Utilizing this broad portfolio of products and services enables our clients to create a more flexible drug development model, which reduces their costs, enhances their productivity and effectiveness to increase speed to market.

 

With over 17,000 employees within 90 facilities in 20 countries around the globe, we are strategically positioned to coordinate worldwide resources and apply multidisciplinary perspectives in resolving our client’s unique challenges. Our client base includes global pharmaceutical companies, biotechnology companies, government agencies and hospitals and academic institutions around the world. And in 2019, revenue increased to $2.62 billion. 

 

At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guide us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. We have proudly supported the development of ~85% of the drugs approved by the FDA in 2019.

  Here in Scotland, based at our site in Tranent, East Lothian, we offer a complete array of Safety Assessment services from complete IND-enabling programs to stand-alone preclinical studies, our preclinical CRO services provide a full range of in vivo and in vitro testing evaluations and regulatory support for the safety assessment of pharmaceuticals, medical devices, and animal health products as well as chemicalsagrochemicals, and biocides. Our scientific and regulatory staff develop and execute individual preclinical studies or customized programs to ensure that drug efficacy and safety assessments are conducted in the most efficient manner.

 

Company info
Website
Mini-site
Charles River Laboratories - Scotland
Location
Elphinstone Research Centre
Tranent Easy
Lothian
EH33 2NE
United Kingdom

Get job alerts

Create a job alert and receive personalised job recommendations straight to your inbox.

Create alert